Michael A. Gibbons

British Thoracic Society quality standards for home oxygen use in adults

W. MacNee, C. Davey, M. Hardinge, 2017, BMJ Open Respiratory Research.

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study

A. Wells, Lavanya Raman, P. Saunders, 2022, ERJ Open Research.

Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Review.

M. Steward, Hannah Thould, Aye Myat Noe Khin, 2023, Immunology and allergy clinics of North America.

Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study

B. Gooptu, H. Adamali, C. Scotton, 2021, BMJ Open Respiratory Research.

Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis

B. Ganeshan, R. Shortman, A. Groves, 2022, medRxiv.

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2020, American journal of respiratory and critical care medicine.

What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures study

P. Cullinan, M. Moffatt, G. Chalmers, 2021, medRxiv.